Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Jun 2025
// FIERCE PHARMA
https://www.fiercebiotech.com/biotech/stuart-sees-dry-eye-disease-drug-fail-phase-3-test-plans-another-study
24 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-initial-results-of-phase-iii-clinical-trial-for-st-100-vezocolmitide-ophthalmic-solution-a-novel-dry-eye-disease-candidate-302489203.html
25 Jul 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-07-25/stuart-therapeutics-taps-dr-lukas-scheibler-as-chief-science-technology-officer/?widget=listSection
25 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-key-addition-to-its-executive-team-302206966.html
29 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-first-patient-first-visit-in-its-phase-3-clinical-trial-of-vezocolmitide-for-dry-eye-disease-302023987.html
18 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-exclusive-worldwide-license-agreement-with-glaukos-corporation-301961150.html
ABOUT THIS PAGE
Stuart Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Isosorbide Dinitrate bulk offered by Stuart Therapeutics